Peter MacCallum Cancer Centre
University of Melbourne, Peter MacCallum Cancer Centre Launch Precision Oncology JV
The institutions aim to improve equitable access to precision oncology advances and patients' outcomes through their collaborative effort.
End-Stage Ovarian Cancer Marked by Rampant Treatment Resistance, Multiple Clones
By profiling multiple tumors per patient, researchers found pronounced polyclonal disease and diverse resistance mechanisms in end-stage high-grade serous ovarian carcinoma.
SEngine Organoid Testing Leads to Treatment Change for Two Metastatic Colorectal Cancer Patients
The researchers said their new study supports the clinical utility of their test, which combines genomic and drug screening analyses of organoids to guide cancer treatment.
Genomic Analyses of Metastatic Lesions in Lethal Breast Cancer Reveal Heterogeneity, Evolution
Researchers analyzed the exomes of metastatic tumor samples from patients who died of breast cancer to piece together the genomic evolution.
Q&A: Peter Mac's Ian Campbell on Cancer Genomics, Next-Gen Technologies, and Research in Australia
Premium
Name: Ian Campbell
Title: Associate professor, Peter MacCallum Cancer Centre